| Structure | Chemical Name | CAS | MF |
|
ALPHA-TRIFLUOROMETHYL-BETA-BUTYROLACTONE
|
174744-18-4
|
C5H5F3O2
|
|
3-Morpholinone,2-hydroxy-4-methyl-,(S)-(9CI)
|
174746-93-1
|
C5H9NO3
|
|
3-Pyrrolidinecarboxylic acid, 1-methyl-5-thioxo-, methyl ester
|
174747-39-8
|
C7H11NO2S
|
|
2-(broMoMethyl)-2-butyl-1-hexanol
|
174747-95-6
|
C11H23BrO
|
|
SODIUM IONOPHORE VIII
|
174752-42-2
|
C45H84O12
|
|
N-(3-dimethylaminodiazenylphenyl)-2-(1-piperidyl)acetamide
|
174752-81-9
|
C15H23N5O
|
|
N-(3-dimethylaminodiazenylphenyl)-2-pyridin-1-yl-acetamide chloride
|
174752-83-1
|
C15H18ClN5O
|
|
N-(3-dimethylaminodiazenylphenyl)-3-pyridin-1-yl-propanamide chloride
|
174752-84-2
|
C16H20ClN5O
|
|
2-chloro-N-(3-dimethylaminodiazenylphenyl)acetamide
|
174752-85-3
|
C10H13ClN4O
|
|
3-Chloro-N-(3-(3,3-dimethyl-1-triazenyl)phenyl)propanamide
|
174752-86-4
|
C11H15ClN4O
|
|
(S)-A-HYDROXY-3-THIOPHENEACETONITRILE
|
174754-56-4
|
C6H5NOS
|
|
(S)-A-HYDROXY-3-FURANACETONITRILE
|
174754-57-5
|
C6H5NO2
|
|
2-Hydroxymethyl Olanzapine
|
174756-45-7
|
C17H20N4OS
|
|
Cyclohexanethiol,5-methyl-2-(1-methylethyl)-,(1R,2R,5S)-(9CI)
|
174757-27-8
|
C10H20S
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde, 2-ethyl-, (1S,2S,4S)- (9CI)
|
174757-35-8
|
C10H14O
|
|
6-SIALYL-N-ACETYLLACTOSAMINE*
|
174757-71-2
|
C25H42N2O19
|
|
(1R,2R)-N,N′-Bis[2-(diphenylphosphino)benzyl]cyclohexane-1,2-diamine
|
174758-63-5
|
C44H44N2P2
|
|
LUVIQUAT (R) HOLD
|
174761-16-1
|
C21H34N4O6S
|
|
[1,2,3]Thiadiazolo[5,4-c]pyridine(9CI)
|
174762-10-8
|
C5H3N3S
|
|
1,2,3-Thiadiazolo[4,5-b]pyridine(9CI)
|
174762-11-9
|
C5H3N3S
|
|
JL 13 compound
|
174762-89-1
|
C21H21ClN4O5
|
|
5-(4-CHLOROBUTYL)-1H-TETRAZOLE
|
174769-79-0
|
C5H9ClN4
|
|
(R)-2-Amino-2-(4-fluorophenyl)ethanol
|
174770-74-2
|
C8H10FNO
|
|
METHYL 9-FLUORENEACETATE 98
|
174770-81-1
|
C16H14O2
|
|
Cyclohexanecarboxylic acid, 4-fluoro-, trans- (9CI)
|
174771-54-1
|
C7H11FO2
|
|
Cyclohexane, 1-ethoxy-4-(trifluoroethenyl)-, trans- (9CI)
|
174771-58-5
|
C10H15F3O
|
|
ETHYL 5-AMINOBENZOFURAN-2-CARBOXYLATE
|
174775-48-5
|
C11H11NO3
|
|
1H-Indene-1-carboxylicacid,2,3-dihydro-6-nitro-,(+)-(9CI)
|
174776-68-2
|
C10H9NO4
|
|
E-2,3-Dimethyl-3-dodecene
|
174783-19-8
|
C14H28
|
|
1-(2-CHLORO-PHENYL)-3,4-DIHYDRO-ISOQUINOLINE
|
174784-50-0
|
C15H12ClN
|
|
anedioic acid, 2-[[(1,1-diMethylethoxy)carbonyl]aMino]-, 8-Methyl ester
|
174784-94-2
|
C14H25NO6
|
|
1-(4-chlorobutyl)cyclopropanol
|
174790-32-0
|
C6H11ClO
|
|
3-broMo-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole
|
174790-35-3
|
C6H7BrN2
|
|
OLANZAPINE N-OXIDE
|
174794-02-6
|
C17H20N4OS
|
|
CBZ-BETA-AMINO-L-ALANINE TERT-BUTYL ESTER HYDROCHLORIDE
|
174796-88-4
|
C15H23ClN2O4
|
|
Tert-butyl N-[2-(benzylaMino)ethyl]carbaMate
|
174799-52-1
|
C14H22N2O2
|
|
FMOC-N-(TERT-BUTYLOXYCARBONYLETHYL)-GLYCINE
|
174799-89-4
|
C24H27NO6
|
|
FMOC-HYP(BZL)-OH
|
174800-02-3
|
C27H25NO5
|
|
tert-butyl (2S,3S)-1-(4-(benzyloxy)phenyl)-4-chloro-3-hydroxybutan-2-ylcarbamate
|
174801-33-3
|
C22H28ClNO4
|
|
4-(trans-4-Ethylcyclohexyl)-2,3′,4′,5′-tetrafluorbiphenyl
|
174805-87-9
|
C20H20F4
|
|
(R)-2-PHTHALIMIDO-3-BUTEN-1-OL
|
174810-06-1
|
C12H11NO3
|
|
(1R,2R)-(+)-1,2-DIAMINOCYCLOHEXANE-N,N'-BIS(2-DIPHENYLPHOSPHINO-1-NAPHTHOYL)
|
174810-09-4
|
C52H44N2O2P2
|
|
AKOS B018292
|
174813-24-2
|
C10H7NOS2
|
|
Chloro{[(1S,2S)-(+)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido}(mesitylene)ruthenium(II), min. 90% RuCl[(S,S)-Tsdpen](mesitylene)
|
174813-81-1
|
C30H30ClN2O3RuS-
|
|
Chloro{[(1R,2R)-(-)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido}(mesitylene)ruthenium(II), min. 90% RuCl[(R,R)-Tsdpen(mesitylene)
|
174813-82-2
|
C30H30ClN2O3RuS-
|
|
4-[Hydroxy(4-Methoxyphenyl)Methyl]benzonitrile
|
174813-84-4
|
C15H13NO2
|
|
2H-1-Benzopyran-3-carboxaldehyde,7-ethoxy-2-oxo-(9CI)
|
174814-75-6
|
C12H10O4
|
|
1H-Pyrazole-4,5-dione,3-methyl-,4-oxime,(E)-(9CI)
|
174816-48-9
|
C4H5N3O2
|
|
Biguanide dinitramide
|
174818-96-3
|
C2H11N9O4
|
|
SE 563
|
174819-21-7
|
C22H17ClF3NO3
|
|
Rabdoketone B
|
174819-51-3
|
C10H12O2
|
|
BIS-MPA-DIALLYL ETHER
|
174822-36-7
|
C11H18O4
|
|
tert-Butyl 4-(2-hydroxyphenyl)piperidine-1-carboxylate
|
174822-86-7
|
C16H23NO3
|
|
(1S)-2,5-Diazabicyclo[2.2.2]octane-2-carboxylic acid 1,1-dimethylethyl ester . HCl
|
174823-32-6
|
C11H21ClN2O2
|
|
2,5-Diazabicyclo[2.2.1]heptane,2-(1,2,4-thiadiazol-5-yl)-,(1S)-(9CI)
|
174823-39-3
|
C7H10N4S
|
|
2,5-Diazabicyclo[2.2.1]heptane,2-(3-methyl-1,2,4-oxadiazol-5-yl)-,(1S)-(9CI)
|
174823-40-6
|
C8H12N4O
|
|
2,5-Diazabicyclo[2.2.1]heptane,2-methyl-5-pyrazinyl-,(1S)-(9CI)
|
174823-41-7
|
C10H14N4
|
|
2-BROMO-3,5-BIS(TRIFLUOROMETHYL)ANILINE
|
174824-16-9
|
C8H4BrF6N
|
|
Ethanone, 2,2,2-trifluoro-1-(4-methyl-2-thiazolyl)- (9CI)
|
174824-73-8
|
C6H4F3NOS
|
|
Ethanone, 1-(4,5-dimethyl-2-thiazolyl)-2,2,2-trifluoro- (9CI)
|
174824-74-9
|
C7H6F3NOS
|
|
Ethanone, 2,2,2-trifluoro-1-(2-thiazolyl)- (9CI)
|
174824-75-0
|
C5H2F3NOS
|
|
Acetic acid, (hexahydro-1-methyl-4H-azepin-4-ylidene)hydrazide (9CI)
|
174826-63-2
|
C9H17N3O
|
|
Benzeneacetaldehyde, alpha-cyclopropyl-4-ethoxy- (9CI)
|
174826-89-2
|
C13H16O2
|
|
2-Benzofuranamine, N-methyl-N-phenyl-
|
174832-50-9
|
C15H13NO
|
|
2-Penten-2-ol, 4-hydroperoxy-4-methyl-, (Z)- (9CI)
|
174834-48-1
|
C6H12O3
|
|
Ethanone, 1-(4,7-dihydro-1,3-dioxepin-2-yl)- (9CI)
|
174836-64-7
|
C7H10O3
|
|
ABZ-ARG-VAL-LYS-ARG-GLY-LEU-ALA-M-NITRO-TYR-ASP-OH
|
174838-79-0
|
C54H84N18O16
|
|
4-Oxazolidinecarboxylicacid,2,2-dimethyl-,methylester,(4S)-(9CI)
|
174840-02-9
|
C7H13NO3
|
|
2H-Imidazol-2-one, 1-acetyl-1,3-dihydro-4,5-dimethyl- (9CI)
|
174840-84-7
|
C7H10N2O2
|
|
2,4-Diazabicyclo[3.1.0]hexan-3-one,1,5-dimethyl-(9CI)
|
174840-87-0
|
C6H10N2O
|
|
6H-Indazol-6-one,7-(diaminomethylene)-2,4,5,7-tetrahydro-(9CI)
|
174841-69-1
|
C8H10N4O
|
|
ETHYL 4-(4-METHOXYPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE
|
174842-34-3
|
C18H19N3O4
|
|
ETHYL 1,3-DIMETHYL-4-(4-FLUOROPHENOXY)-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE
|
174842-35-4
|
C17H16FN3O3
|
|
ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE
|
174842-36-5
|
C17H15Cl2N3O3
|
|
5,7-BIS(TRIFLUOROMETHYL)-3-CYANO-2-(METHYLTHIO)PYRAZOLO[1,5-A]PYRIMIDINE
|
174842-48-9
|
C10H4F6N4S
|
|
ETHYL 5-CHLOROPYRAZOLO[1,5-A]QUINAZOLINE-3-CARBOXYLATE
|
174842-56-9
|
C13H10ClN3O2
|
|
2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)aMino]-2-deoxy-D-glucose
|
174844-42-9
|
C12H14N4O8
|
|
Benzaldehyde, 4-nitro-, oxime, radical ion(1-), (Z)- (9CI)
|
174848-02-3
|
C7H6N2O3
|
|
Benzaldehyde, 4-nitro-, oxime, radical ion(2-) (9CI)
|
174848-04-5
|
C7H6N2O3
|
|
Benzeneacetonitrile, 4-nitro-, radical ion(2-) (9CI)
|
174848-08-9
|
C8H6N2O2
|
|
(S)-2-HYDROXY-2,4-DIMETHYL-PENTANENITRILE
|
174849-23-1
|
C7H13NO
|
|
Pyridine, 2-(4-methyl-2-oxido-1,2,3-oxathiazolidin-3-yl)-, (4R)- (9CI)
|
174854-83-2
|
C8H11N2O2S-
|
|
Pyridine, 2-(5-methyl-2-oxido-1,2,3-oxathiazolidin-3-yl)-, (2R-trans)- (9CI)
|
174854-86-5
|
C8H10N2O2S
|
|
4-Aminoindole
|
174854-93-4
|
C8H8N2.ClH
|
|
TERT-BUTYL 4-[2-(AMINOMETHYL)PHENYL]PIPERAZINE-1-CARBOXYLATE
|
174855-53-9
|
C16H25N3O2
|
|
1-Boc-4-(2-formylphenyl)piperazine
|
174855-57-3
|
C16H22N2O3
|
|
Benzyl 2-Acetamido-2-deoxy-4-O-b-D-galactofuranosyl-a-D-glucopyranoside
|
174866-45-6
|
C21H31NO11
|
|
1-Isoquinolinecarbonyl chloride, 8-methyl- (9CI)
|
174873-76-8
|
C11H8ClNO
|
|
1-Chrolo-8-Methylisoquinoline
|
174873-81-5
|
C10H8ClN
|
|
N-(2-aminoethyl)-2-(methylamino)benzamide
|
174878-15-0
|
C10H15N3O
|
|
4-bromo-N-(6-methylpyridin-2-yl)benzamide
|
174878-38-7
|
C13H11BrN2O
|
|
FMOC-DL-O-TYROSINE
|
174879-27-7
|
C24H21NO5
|
|
FMOC-DL-2-AMINOBUTYRIC ACID
|
174879-28-8
|
C19H19NO4
|
|
HUMAN PARAINFLUENZA VIRUS TYPE 3 FUSION
|
174881-94-8
|
C183H294N54O59
|
|
PYCNOGENOL
|
174882-69-0
|
unspecified
|
|
4-(4-Acetyl-2-Methoxyphenoxy)-butanoic Acid Ethyl Ester
|
174884-21-0
|
C15H20O5
|
|
5-[(4-ACETYLPHENYL)AMINO]-5-OXOPENTANOIC ACID
|
174885-31-5
|
C13H15NO4
|
|
(2-AMINO-2-PHENYL-ETHYL)-CARBAMIC ACID TERT-BUTYL ESTER
|
174885-99-5
|
C13H20N2O2
|
|
5-(trifluoroMethyl)thiazol-2-aMine hydrochloride
|
174886-03-4
|
C4H4ClF3N2S
|
|
1,1,1-Trifluoro-2-Methyl-
|
174886-04-5
|
C4H9ClF3N
|